Scalar Market Research

Prescription Pharmaceuticals Market Worth USD 918.74 Billion by 2020 - Scalar Market Research

Our industry experts anticipate that within the prescription pharmaceuticals market, the infectious disease will be the fastest-growing therapeutic segment, growing at a CAGR ranging from 5% to 10% by 2020. In addition, capsules will be the largest as well as the fastest-growing formulation segment, growing at a CAGR ranging from 5% to 10% by 2020. The Asia-Pacific region will be the fastest-growing geographic segment of the market, growing at a CAGR of more than 6% during the forecast period.


Chicago, IL -- (SBWIRE) -- 03/01/2017 -- According to the new market research report, "Prescription Pharmaceuticals Market by Therapeutic Segments (Cardiovascular Disorders, Inflammatory Conditions, Metabolic Disorders, Oncology, Respiratory Disorders, Others), Formulations (Capsules, Inhalants, Parenterals, Tablets, Topicals) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2020", published by Scalar Market Research, the global prescription pharmaceuticals market is expected to grow from USD 761.85 billion in 2016 and reach USD 918.74 billion by 2020, growing at a CAGR of 4.8% during the forecast period.

The global prescription pharmaceuticals market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium trends and forecast to 2020. It also focuses on the key drivers and opportunities in this market.

Request Sample:

Buyers can expect to receive 10% customization on this report.

Key findings of the report:

1. Improved life expectancy resulting into increased number of aging population and the growing prevalence of chronic diseases are expected to be the major driving factors for the prescription pharmaceuticals market during the forecast period.

2. The rising affluence in the emerging market, rise in the awareness, and the changing healthcare infrastructure across the developing countries are also some of the major drivers for the prescription pharmaceuticals market.

3. The rising costs of the management of chronic diseases, overall rise in the average age, and the rise in the use and demand for the legal medical prescriptions are also highlighted as some of the major growth drivers for the prescription pharmaceuticals market in the near future.

Cardiovascular disorders expected to dominate the therapeutic segment of the market:

According to the report, the cardiovascular disorders are expected to hold the largest share of the therapeutic segment of the prescription pharmaceuticals market, during the forecast period. The infectious diseases segment, on the other hand, is expected to become the fastest-growing segment. The major driving factors for these segments include the rise in aging population, changing lifestyles, and the growing demand from the emerging markets.

North America: Leading the prescription pharmaceuticals market:

According to the prescription pharmaceuticals report, the North America region is expected to hold the largest market share during the forecast period. The major driving factors for the region include the rapid technological advancements, positive government initiatives, and the rising instances of chronic diseases. The Asia-Pacific region, on the other hand, is expected to be the fastest-growing geographic region in this market in the near future.

Browse Report Summary:

The report includes some of the key players from the prescription pharmaceuticals market, which include:

1. AG, Gilead Sciences, Inc.
2. AstraZeneca plc
3. GlaxoSmithKline plc,
4. Johnson & Johnson,
5. Merck & Co, A.G.,
6. Pfizer, Inc.
7. F. Hoffmann-La Roche
8. Others

About Scalar Market Research
Scalar Market Research, Inc. is a Chicago, U.S.-based market research and consulting firm that serves Fortune 1000 companies, leading businesses and upcoming organizations from around the world to help them achieve their business goal of sustainable revenue growth, utilizing Scalar's premium market research reports and consulting services to make critical strategic decisions.

Our real-time industry data tracking, with the help of advanced analytics and machine learning, offers our clients highly accurate 360-degree perspective of key developments in niche markets. Our team of industry experts, with a thorough understanding of global markets and cumulative industry experience spanning 100+ years, work relentlessly to help our clients realize their most important business goals.

Find out more about our services at:

Mr.Moses Nakka,
8770 W Bryn Mawr Ave.,
Suite 1300
Chicago, IL 60631
Tel.: 800-213-5170 (U.S./Canada Toll-free)

Follow us on LinkedIn: